Leadership Overview
Cynosure Lutronic has 8 executives leading key functions including strategic direction, financial oversight, operational management, and legal compliance.
Dedicated to advancing energy-based medical technology, Cynosure Lutronic delivers innovative aesthetic treatment systems to practitioners worldwide while maintaining a commitment to clinical excellence and patient outcomes.
Dedicated to advancing energy-based medical technology, Cynosure Lutronic delivers innovative aesthetic treatment systems to practitioners worldwide while maintaining a commitment to clinical excellence and patient outcomes.
Leadership Roles at Cynosure Lutronic
Nadav Tomer - Chief Executive Officer
Nadav Tomer, the Chief Executive Officer at Cynosure Lutronic, directs the global vision for energy-based aesthetic and medical treatment systems. Overseeing the development of diverse applications for hair removal and skin revitalization, the Chief Executive Officer ensures alignment between engineering innovation and market demand. This leadership role involves constant collaboration with the Board to scale manufacturing capabilities across international territories. By prioritizing research and development, Nadav Tomer drives the company toward market leadership in body contouring and gynecological health solutions. The Chief Executive Officer maintains a focus on long-term growth, ensuring that every medical device meets the highest standards of efficacy for practitioners. Through strategic resource allocation, the Chief Executive Officer secures the competitive position of the organization within the global medical technology landscape, ultimately fostering a culture of continuous improvement and technological advancement for all clinical partners.
Timothy Gehlmann - Chief Executive Officer & President, Hoya Photonics Inc & of Hoya Photonics Inc
Timothy Gehlmann, the Chief Executive Officer & President, Hoya Photonics Inc & of Hoya Photonics Inc at Cynosure Lutronic, manages the integration of advanced photonics into aesthetic treatment platforms. Overseeing the technical synergy between laser components and medical applications, the Chief Executive Officer & President, Hoya Photonics Inc & of Hoya Photonics Inc ensures that hardware manufacturing meets rigorous quality benchmarks. This role involves coordinating with internal engineering teams to refine scar reduction and skin revitalization technologies. By optimizing supply chain logistics for specialized optical components, Timothy Gehlmann supports the broader mission of delivering best-in-class medical systems. The Chief Executive Officer & President, Hoya Photonics Inc & of Hoya Photonics Inc facilitates cross-functional communication to accelerate product development cycles. Through technical oversight, the Chief Executive Officer & President, Hoya Photonics Inc & of Hoya Photonics Inc guarantees that the company maintains a technological edge in the competitive energy-based treatment market, providing practitioners with reliable, high-performance tools for patient care.
Cyriacus Njoku - Chief Executive Officer & President
Cyriacus Njoku, the Chief Executive Officer & President at Cynosure Lutronic, governs the overarching business strategy and corporate governance frameworks. Overseeing the expansion of aesthetic treatment portfolios, the Chief Executive Officer & President ensures that the company addresses evolving needs in gynecological health and body contouring. This leadership position requires constant engagement with stakeholders to maintain operational excellence across all manufacturing divisions. By fostering partnerships with physicians and aesthetic business owners, Cyriacus Njoku drives the adoption of new treatment modalities. The Chief Executive Officer & President monitors market trends to identify opportunities for portfolio diversification, ensuring that the organization remains at the forefront of medical innovation. Through disciplined management of corporate resources, the Chief Executive Officer & President supports the delivery of advanced systems to global markets, ultimately strengthening the reputation of the company as a premier provider of energy-based medical solutions for diverse patient populations.
Bob Howe - Chief Financial Officer
Bob Howe, the Chief Financial Officer at Cynosure Lutronic, manages the fiscal health and capital allocation strategies for the organization. Overseeing financial planning, reporting, and risk management, the Chief Financial Officer ensures that investments in manufacturing and research remain sustainable. This role involves analyzing market performance data to support the development of hair removal and skin revitalization systems. By optimizing the cost structure of production, Bob Howe enables the company to scale operations efficiently while maintaining high profit margins. The Chief Financial Officer collaborates with other executive leaders to align budgetary goals with long-term growth objectives. Through rigorous financial oversight, the Chief Financial Officer secures the capital necessary for innovation in scar reduction and body contouring technologies. Bob Howe provides the analytical foundation for strategic decision-making, ensuring that the company maintains a robust balance sheet while continuing to deliver cutting-edge medical treatment systems to practitioners and physicians across the globe.
Baker Baker - Executive Vice President & Chief Financial Officer
Baker Baker, the Executive Vice President & Chief Financial Officer at Cynosure Lutronic, directs the enterprise-wide financial strategy and operational efficiency initiatives. Overseeing the integration of financial systems with manufacturing workflows, the Executive Vice President & Chief Financial Officer ensures that resource distribution supports the development of gynecological health and aesthetic treatment platforms. This role involves managing complex fiscal structures to facilitate international market expansion. By implementing advanced financial modeling, Baker Baker identifies opportunities for cost reduction and revenue growth within the medical device sector. The Executive Vice President & Chief Financial Officer works closely with the leadership team to evaluate the financial viability of new product launches. Through strategic oversight of capital expenditures, the Executive Vice President & Chief Financial Officer ensures that the company remains well-positioned to invest in future technologies. Baker Baker maintains a focus on long-term value creation, supporting the mission of providing innovative, high-quality treatment systems to a global network of aesthetic business owners.
Christopher Aronson - President (North America)
Christopher Aronson, the President (North America) at Cynosure Lutronic, directs the commercial strategy and market penetration efforts across the North American region. Overseeing sales teams and clinical education programs, the President (North America) ensures that practitioners and physicians have access to the latest energy-based treatment systems. This role involves building strong relationships with aesthetic business owners to drive the adoption of hair removal and skin revitalization technologies. By analyzing regional market data, Christopher Aronson identifies growth opportunities and tailors marketing initiatives to meet local demand. The President (North America) collaborates with the executive team to ensure that regional sales targets align with the overall corporate mission. Through effective leadership of the North American sales force, the President (North America) secures a dominant market position for the company. Christopher Aronson maintains a focus on customer success, ensuring that the organization provides exceptional support and training to all clinical partners throughout the region.
Jae Yoo - Chief Operations Officer
Jae Yoo, the Chief Operations Officer at Cynosure Lutronic, manages the end-to-end manufacturing and distribution processes for all energy-based treatment systems. Overseeing production facilities and quality control protocols, the Chief Operations Officer ensures that every device meets stringent medical standards before reaching practitioners. This role involves streamlining the supply chain to support the rapid delivery of hair removal and skin revitalization technologies. By optimizing operational workflows, Jae Yoo increases manufacturing throughput and reduces lead times for global customers. The Chief Operations Officer coordinates with engineering and sales teams to ensure that product availability aligns with market demand. Through the implementation of lean manufacturing principles, the Chief Operations Officer drives efficiency across the production lifecycle. Jae Yoo maintains a focus on operational scalability, ensuring that the company can meet the growing needs of the aesthetic market while upholding the highest levels of product reliability and safety for patients and physicians worldwide.
Sean Flanagan - Chief Legal Officer
Sean Flanagan, the Chief Legal Officer at Cynosure Lutronic, directs the legal strategy, intellectual property protection, and regulatory compliance frameworks. Overseeing the legal aspects of product development for scar reduction and body contouring systems, the Chief Legal Officer ensures that all innovations adhere to international medical device regulations. This role involves managing complex contractual agreements with global distributors and clinical partners. By mitigating legal risks, Sean Flanagan protects the proprietary technology that defines the company as a leader in the aesthetic industry. The Chief Legal Officer provides guidance on corporate governance and ethical standards, ensuring that all business practices align with the mission of the organization. Through proactive legal management, the Chief Legal Officer supports the expansion of the company into new geographic markets. Sean Flanagan ensures that the company maintains a secure legal foundation, allowing the business to focus on delivering advanced treatment solutions to practitioners and patients with confidence and integrity.
Explore Leadership Teams in Manufacturing
Ansell is a global manufacturer specializing in health and safety protection solutions. Founded in 1893, the company designs and produces a comprehensive range of protective equipment and products that enhance human wellbeing across various industries. Ansell operates internationally with a presence in North America, Europe, Asia Pacific, and other regions, offering innovative safety solutions for industrial, medical, and consumer applications.
Company Leadership NS
CD
Accuray develops and manufactures advanced radiation oncology systems designed to deliver precise cancer treatment solutions. The company specializes in creating innovative medical devices that enable clinicians to target tumors with exceptional accuracy while minimizing exposure to surrounding healthy tissue. This focus on precision has shaped the organization's technical approach and product development strategy across its portfolio. The company's radiation oncology systems integrate sophisticated imaging, planning, and delivery technologies to support comprehensive cancer care. By combining real-time imaging capabilities with adaptive treatment planning, Accuray's platforms allow medical teams to adjust therapy in response to anatomical changes during treatment courses. This technological integration addresses a critical challenge in oncology: maintaining treatment efficacy while reducing potential side effects that can impact patient quality of life. Accuray serves hospitals, cancer treatment centers, and specialized radiation oncology facilities globally. The company's systems support treatment of various cancer types across different anatomical sites, from brain and head-and-neck tumors to thoracic and abdominal malignancies. Healthcare providers rely on Accuray's technology to expand their treatment capabilities and improve clinical outcomes for patients who might otherwise have limited options.
Company Leadership MR
ResMed is a global healthcare technology company that develops innovative medical devices, digital health solutions, and cloud-connected software to improve the diagnosis, treatment, and management of sleep disorders, respiratory conditions, and care delivered outside traditional hospital settings. The company partners with healthcare providers, patients, and caregivers to enhance health outcomes, streamline care delivery, and improve quality of life through connected technologies, data-driven insights, and ongoing innovation in medical care.
Company Leadership
AP
NM
Miracle-Ear, a division of Amplifon Group, has been a trusted resource in hearing solutions for over 70 years. Based in Minneapolis, MN, Miracle-Ear specializes in customizable hearing solutions that feature discreet, comfortable products designed to meet each individual's hearing loss needs.
Company Leadership PK
BR
RH
JC
Frequently Asked Questions Regarding Cynosure Lutronic Top Executives and Leadership Team
Unlock more people and company data
